DW Cefaly Holding
0725.837.241 · rovalta.com · 24/09/2026
ACTIVE
DW Cefaly Holding
Financial year 2024 · Closed on 31/12/2024
Net result-127,2 k €-19,3 %over 1 year
Equity29,2 M €-0,4 %over 1 year
Overview
Identity
Source · BCE/KBODW Cefaly Holding is a Private limited company incorporated in 2019. Its registered office is in Liège.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0725.837.241
- Incorporation
- 29/04/2019
- Legal form
- Private limited company
- Registered office
- Boulevard de Patience et Beaujonc 3
4000 Liège · WallonieSee on map - Contributed capital
- 36 096 977,71 €
- Latest accounts
- 31/12/2024
Signals
Solid equity
Financials
Source · NBB, 5 filingsTrend over 5 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| EBITDA | -24,5 k € | +44.3% | -44 k € | +64.1% | -122,5 k € | -103% | -60,4 k € | +40.0% | -100,7 k € |
| Operating result | -121,8 k € | -15.8% | -105,1 k € | +42.8% | -183,7 k € | -51.1% | -121,6 k € | -12.9% | -107,7 k € |
| Net result | -127,2 k € | -19.3% | -106,6 k € | +45.5% | -195,6 k € | -60.4% | -122 k € | +98.1% | -6,3 M € |
| Balance sheet | |||||||||
| Equity | 29,2 M € | -0.4% | 29,3 M € | -0.4% | 29,4 M € | -0.7% | 29,6 M € | -0.4% | 29,8 M € |
| Total assets | 29,9 M € | -0.0% | 29,9 M € | -0.1% | 29,9 M € | -0.1% | 29,9 M € | +0.2% | 29,9 M € |
| Cash | 4,2 k € | -29.2% | 5,9 k € | -4.4% | 6,2 k € | -62.1% | 16,4 k € | +7789% | 207,3 € |
| Debts | 378,7 k € | +8.0% | 350,5 k € | +1.9% | 343,8 k € | +51.5% | 226,9 k € | +141% | 94,1 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 25 M€ and 50 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20249 active · 2 ended
Active mandates
Andy Page
ActiveCameron McDavid
ActiveAndrew Carragher
ActiveGabriel Becher
ActiveJeffrey Hicks
ActiveJennifer Trainor-Mcdermott
ActiveJohn Benear II
ActivePierre Rigaux
ActiveRobert Wilkins
ActiveEnded mandates
Jennifer Trainor-McDermott
EndedRobert Wilkins
EndedOther companies at this address
Boulevard de Patience et Beaujonc 3 4000 Liège| Company | CBE no. |
|---|---|
Abscint● Active | 0749.828.410 |
AMPACIMON● Active | 0827.990.317 |
Amyl Therapeutics● Active | 0758.775.372 |
BECARV● Bankrupt | 0840.777.885 |
BE.SPINE● Active | 1013.110.857 |
CEFALY Technology● Active | 0870.578.661 |
DERMAX● Active | 0667.730.677 |
DIANOSIC● Active | 1034.558.646 |
| 1023.778.481 | |
EXO Biologics● Active | 0732.982.379 |
ExoXpert● Active | 1003.807.666 |
Hirundo Biosciences● Active | 0681.855.065 |
HolyFox Invest● Active | 1010.693.181 |
Hyloris● Active | 0669.738.676 |
Hyloris Developments● Active | 0542.737.368 |
Hyloris Pharmaceuticals● Active | 0674.494.151 |
Hyloris Therapeutics● Active | 1025.029.385 |
LEGIAPARK● Active | 0728.589.170 |
MAN & SCIENCE● Active | 0837.403.770 |
ONCORADIOMICS● Active | 0662.719.440 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 29/04/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 21 months |
| Filing date | 09/10/2025 | 10/02/2025 | 10/02/2025 | 10/02/2025 | 10/02/2025 |
| General meeting | 29/09/2025 | 20/01/2025 | 20/01/2025 | 20/01/2025 | 20/01/2025 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 5 filingsValuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 25 M€ and 50 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20249 active · 2 ended
Active mandates
Andy Page
ActiveCameron McDavid
ActiveAndrew Carragher
ActiveGabriel Becher
ActiveJeffrey Hicks
ActiveJennifer Trainor-Mcdermott
ActiveJohn Benear II
ActivePierre Rigaux
ActiveRobert Wilkins
ActiveEnded mandates
Jennifer Trainor-McDermott
EndedRobert Wilkins
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates07/08/2026DEMISSIONS, NOMINATIONS
- Mandates08/04/2026STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Mandates18/11/2025DEMISSIONS, NOMINATIONS
- Mandates19/03/2025DEMISSIONS, NOMINATIONS
- Mandates28/11/2024DEMISSIONS, NOMINATIONS
- Registered office26/09/2024SIEGE SOCIAL
- Capital / shares25/08/2021CAPITAL, ACTIONS - DIVERS
- Capital / shares25/01/2021STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024-127,2 k €↓
- 2023Annual accounts 2023-106,6 k €↑
- 2022Annual accounts 2022-195,6 k €↓
- 2021Annual accounts 2021-122 k €↑
- 2020Annual accounts 2020-6,3 M €
- 29/04/2019IncorporationPrivate limited company